Results 231 to 240 of about 3,997,149 (388)

Literature‐informed ensemble machine learning for three‐year diabetic kidney disease risk prediction in type 2 diabetes: Development, validation, and deployment of the PSMMC NephraRisk model

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Introduction Diabetic kidney disease (DKD) and diabetic nephropathy (DN) affect around 40% of diabetic patients but lack accurate risk prediction tools that include social determinants and demographic complexity. We developed and validated an ensemble machine learning model for three‐year DKD/DN risk prediction with deployment readiness ...
Ayla M. Tourkmani, Turki J. Al‐Harbi, Ahmad Abdullah Alghamdi, Ibrahim M. Youzghadli, Faris Saad Alosaimi, Ahmed Y. Azzam   +5 more
wiley   +1 more source

The Relationship Between Oxidative Stress and Infertility Due to Antihypertensive Drugs in Rattus Norvegicus [PDF]

Berna Asır, Yakup Kumtepe
openalex   +1 more source

Antihypertensive Drug Regimen for High Blood Pressure Associated with Modifiable Cardiovascular Risk Factors Among Hypertensive Patients Attending Campus Teaching Hospital of Lomé, Togo, West Africa [PDF]

, 2018
Yao Potchoo
openalex   +1 more source

Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study. [PDF]

Age Ageing
Cheung ECL, Adesuyan M, Szilcz M, Kalisch Ellett LM, Shah S, Jani YH, Hägg S, Pratt N, Lau KK, Luo H, Wan EYF, Chan EWY, Wong ICK, Yuen JK, Yiu KH, Howard R, Brauer R, Chui CSL.   +17 more
europepmc   +1 more source

Differential Cardiovascular Outcomes of Each Antihypertensive Drug Class in Patients With Hypertension and Breast Cancer Undergoing Doxorubicin-Containing Chemotherapy. [PDF]

J Breast Cancer, 2023
Hwang HJ, Han SA.
europepmc   +1 more source

Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double‐blind, multicentre, therapeutic confirmatory phase 3 clinical trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim This study evaluated the efficacy and safety of empagliflozin 10 and 25 mg compared to placebo as add‐on treatment for people with type 2 diabetes mellitus (T2DM) uncontrolled after ≥8 weeks of treatment with metformin and sitagliptin. Materials and Methods A randomised, double‐blind, multicentre, therapeutic confirmatory, phase 3 clinical
Seung‐Hwan Lee, Kyung Ah Han, Eun‐Gyoung Hong, Jun Goo Kang, Choon Hee Chung, Jong Chul Won, Eon Ju Jeon, Jung‐Hwan Cho, Ho Chan Cho, Sin Gon Kim, Eun Seok Kang, So Hun Kim, Hae Jin Kim, In‐Kyung Jeong, Sung Wan Chun, Young Min Cho   +15 more
wiley   +1 more source

Non-compliance with antihypertensive drug therapy: a risk factor for stroke among black hypertensives.

, 1990
M J Akpaffiong
openalex   +1 more source

Drug Side Effect Symptoms and Adherence to Antihypertensive Medication.

American Journal of Hypertension, 2016
Y. Tedla, L. Bautista
semanticscholar   +1 more source

Association of antihypertensive drug target genes with alzheimer's disease: a mendelian randomization study. [PDF]

Alzheimers Res Ther
Zheng H, Chen C, Feng Y.
europepmc   +1 more source

Impact of Antihypertensive Drug Class on Outcomes in SPRINT. [PDF]

Hypertension, 2022
DeCarolis DD, Gravely A, Olney CM, Ishani A.   +3 more
europepmc   +1 more source